Table 1. Baseline characteristics of the patients with NMIBC or MIBC and information at follow-up.
| VARIABLES | NMIBC (n= 230) |
MIBC (n= 25) |
|---|---|---|
| N (%) | N (%) | |
| Age (years) | ||
| Mean ± SD | 63.8 ± 8.0 | 64.7 ± 8.6 |
| Range | 40.0-74.9 | 40.2-73.5 |
| Smoking Status | ||
| Never | 22 (9.6) | 3 (12.0) |
| Former | 121 (52.6) | 9 (36.0) |
| Current | 87 (37.8) | 13 (52.0) |
| T stage | ||
| Tx | 2 (0.9) | - |
| Ta | 147 (63.9) | - |
| Tis | 7 (3.0) | - |
| T1 | 74 (32.2) | - |
| T2 | - | 23 (92.0) |
| T3+T4 | - | 2 (8.0) |
| Grading (1973) | ||
| G1 | 70 (30.4) | - |
| G2 | 99 (43.0) | 1 (4.0) |
| G3 | 61 (26.6) | 24 (96.0) |
| Grading (2004) | ||
| Low grade | 125 (54.3) | - |
| High grade | 105 (45.7) | 25 (100.0) |
| Tumor size (cm) | ||
| <3 | 168 (73.0) | 7 (28.0) |
| ≥3 | 62 (27) | 18 (72.0) |
| Risk | ||
| Low-risk | 60 (26.1) | - |
| Intermediate Risk | 78 (33.9) | - |
| High-risk | 92 (40.0) | - |
| Recurrence | ||
| No | 142 (61.7) | - |
| Yes | 88 (38.3) | - |
| Number of recurrences | ||
| 1 | 56 (63.6) | - |
| 2 | 21 (23.9) | - |
| ≥3 | 11 (12.5) | - |
| Progression to MIBC | ||
| No | 220 (95.7) | - |
| Yes | 10 (4.3) | - |
| Therapy | ||
| No | 110 (47.8) | 22 (88.0) |
| Yes | 120 (52.2) | 3 (12.0) |
| Type | ||
| BCG | 67 (55.8) | - |
| Chemotherapy | 53 (44.2) | 3 (100.0) |
| Cystectomy | ||
| No | 209 (90.9) | 6 (24.0) |
| Yes | 21 (9.1) | 19 (76.0) |
| Disease relapse after cystectomy | ||
| No | 14 (66.7) | 9 (47.4) |
| Yes | 7 (33.3) | 10 (52.6) |
| Type | ||
| Local | 3 (42.8) | 3 (30.0) |
| Distal | 2 (28.6) | 1 (10.0) |
| Local+Distal | 2 (28.6) | 6 (60.0) |
| Status at follow-up | ||
| Alive | 198 (86.1) | 9 (36.0) |
| Dead of all causes | 32 (13.9) | 16 (64.0) |
| Dead of bladder cancer | 11 (4.8) | 9 (36.0) |